ALLIED HEALTHCARE PRODUCTS INC: Nasdaq/NYSE listing notice — Allied Healthcare receives Nasdaq deficiency notice for delayed Q3 10-Q filing

ALLIED HEALTHCARE PRODUCTS INC

Notice received Nov 23, 2022 for non-compliance with Nasdaq Listing Rule 5250(c)(1) due to late Form 10-Q.
Company has 60 days to submit a plan to regain compliance with Nasdaq listing standards.
Delayed filing for quarter ended September 30, 2022; no further financial impact disclosed.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ALLIED HEALTHCARE PRODUCTS INC received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

November 23, 2022, Allied Healthcare Products, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that, as a result of its delay in filing its Form 10-Q for the quarter ended September 30, 2022, it is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). The Company has a period of 60 days from its receipt of the notice to submit a plan to regain compliance with the Nasdaq Listing Rules.

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-22-122370

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.